These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 2116484

  • 1. Recognition of keratinocytes by cytotoxic T cells specific for conventional HLA class-I alloantigen.
    Symington FW, Santos EB.
    J Invest Dermatol; 1990 Aug; 95(2):224-8. PubMed ID: 2116484
    [Abstract] [Full Text] [Related]

  • 2. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes.
    Symington FW, Santos EB.
    J Immunol; 1991 Apr 01; 146(7):2169-75. PubMed ID: 1672345
    [Abstract] [Full Text] [Related]

  • 3. Lysis of keratinocytes by IL-2-activated peripheral blood lymphocytes.
    Symington FW, Santos EB.
    J Invest Dermatol; 1991 Jan 01; 96(1):127-33. PubMed ID: 1987288
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.
    Leggatt GR, Dunn LA, De Kluyver RL, Stewart T, Frazer IH.
    Immunol Cell Biol; 2002 Oct 01; 80(5):415-24. PubMed ID: 12225377
    [Abstract] [Full Text] [Related]

  • 5. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.
    LeMay LG, Kan-Mitchell J, Goedegebuure P, Harel W, Mitchell MS.
    Cancer Immunol Immunother; 1993 Aug 01; 37(3):187-94. PubMed ID: 8101473
    [Abstract] [Full Text] [Related]

  • 6. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
    Nguyen T, Naziruddin B, Dintzis S, Doherty GM, Mohanakumar T.
    Int J Cancer; 1999 May 17; 81(4):607-15. PubMed ID: 10225452
    [Abstract] [Full Text] [Related]

  • 7. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 17; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 8. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
    Yasumura S, Weidmann E, Hirabayashi H, Johnson JT, Herberman RB, Whiteside TL.
    Int J Cancer; 1994 May 01; 57(3):297-305. PubMed ID: 8168988
    [Abstract] [Full Text] [Related]

  • 9. Primary alloreactive cytotoxic T-lymphocytes are not commonly restricted by self-HLA class I antigens.
    Young NT, Roelen DL, Wood KJ, Welsh KI, Morris PJ, Dallman MJ.
    Hum Immunol; 1996 Sep 15; 50(1):38-46. PubMed ID: 8872173
    [Abstract] [Full Text] [Related]

  • 10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 11. Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.
    Wölfel T, Herr W, Coulie P, Schmitt U, Meyer zum Büschenfelde KH, Knuth A.
    Int J Cancer; 1993 Jun 19; 54(4):636-44. PubMed ID: 8514455
    [Abstract] [Full Text] [Related]

  • 12. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M, Huber C, Auböck J, Pohl-Markl H, Troppmair J, Herold M, Gächter A, Nussbaumer W, Böck G, Nachbaur D.
    Immunology; 1994 Apr 19; 81(4):569-77. PubMed ID: 7913694
    [Abstract] [Full Text] [Related]

  • 13. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
    De Bueger M, Bakker A, Van Rood JJ, Goulmy E.
    Eur J Immunol; 1991 Nov 19; 21(11):2839-44. PubMed ID: 1682155
    [Abstract] [Full Text] [Related]

  • 14. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB, Whiteside TL.
    Cancer Res; 1991 Nov 15; 51(22):6153-62. PubMed ID: 1718596
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells.
    Mutis T, De Bueger M, Bakker A, Ottenhoff TH.
    Scand J Immunol; 1993 Jan 15; 37(1):43-51. PubMed ID: 8418472
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.
    Mazzocchi A, Anichini A, Castelli C, Sensi M, Poli F, Russo C, Parmiani G.
    Cancer Immunol Immunother; 1990 Jan 15; 32(1):13-21. PubMed ID: 2149669
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.